{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:54:34Z","timestamp":1790096074600,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LY21H310001"],"award-info":[{"award-number":["LY21H310001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073927"],"award-info":[{"award-number":["82073927"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.tox.2024.153757","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T04:46:50Z","timestamp":1707972410000},"page":"153757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice"],"prefix":"10.1016","volume":"503","author":[{"given":"Mingyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minlei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luexiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2024.153757_bib1","first-page":"400","article-title":"Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions","volume":"11","author":"Ahlin","year":"2011","journal-title":"Pharm. J."},{"key":"10.1016\/j.tox.2024.153757_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jconrel.2021.03.013","article-title":"pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects","volume":"332","author":"Albuquerque","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.tox.2024.153757_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9030035","article-title":"Pharmacokinetic and toxicodynamic characterization of a novel doxorubicin derivative","volume":"9","author":"Alrushaid","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tox.2024.153757_bib4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/db07-1515","article-title":"Interaction of oral antidiabetic drugs with hepatic uptake transporters -: focus on organic anion transporting polypeptides and organic cation transporter 1","volume":"57","author":"Bachmakov","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.tox.2024.153757_bib5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.bjc.6605587","article-title":"Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide","volume":"102","author":"Bray","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tox.2024.153757_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/dmd.119.089326","article-title":"Carbonyl reductase 1 plays a significant role in converting doxorubicin to cardiotoxic doxorubicinol in mouse liver, but the majority of the doxorubicinol-forming activity remains unidentified","volume":"48","author":"Breysse","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2024.153757_bib7","doi-asserted-by":"crossref","DOI":"10.4103\/2141-9248.126619","article-title":"An evaluation of hepatotoxicity in breast cancer patients receiving injection doxorubicin","volume":"4","author":"Damodar","year":"2014","journal-title":"Ann. Med. Health Sci. Res."},{"key":"10.1016\/j.tox.2024.153757_bib8","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2352-3026(18)30177-7","article-title":"Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study","volume":"5","author":"Dunleavy","year":"2018","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.tox.2024.153757_bib9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ijc.28797","article-title":"In vivo disposition of doxorubicin is affected by mouse Oatp1a\/1b and human OATP1A\/1B transporters","volume":"135","author":"Durmus","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tox.2024.153757_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1097\/FPC.0b013e3283559b22","article-title":"Metformin pathways: pharmacokinetics and pharmacodynamics","volume":"22","author":"Gong","year":"2012","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.tox.2024.153757_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-014-2913-y","article-title":"Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancer","volume":"145","author":"Hashimoto","year":"2014","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.tox.2024.153757_bib12","article-title":"Targeting OCT3 attenuates doxorubicin-induced cardiac injury","volume":"118","author":"Huang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tox.2024.153757_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.toxlet.2019.08.013","article-title":"Up-regulation of hepatic fatty acid transporters and inhibition\/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis","volume":"316","author":"Jiang","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2024.153757_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.103.053298","article-title":"Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3)","volume":"308","author":"Jonker","year":"2004","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tox.2024.153757_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.116.105544","article-title":"Contribution of organic anion-transporting polypeptides 1A\/1B to doxorubicin uptake and clearance","volume":"91","author":"Lee","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2024.153757_bib16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bdd.2229","article-title":"Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically-based pharmacokinetic modeling","volume":"41","author":"Lee","year":"2020","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.tox.2024.153757_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/IJN.S187888","article-title":"Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency","volume":"14","author":"Li","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.tox.2024.153757_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cvr\/cvx078","article-title":"Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity","volume":"114","author":"Lother","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.tox.2024.153757_bib19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.7314\/APJCP.2014.15.4.1639","article-title":"In vitro modulation of P-glycoprotein, MRP-1 and BCRP expression by mangiferin in doxorubicin-treated MCF-7 cells","volume":"15","author":"Louisa","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.tox.2024.153757_bib20","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jat.4109","article-title":"Downregulation of glucose-6-phosphatase expression contributes to fluoxetine-induced hepatic steatosis","volume":"41","author":"Lu","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2024.153757_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.xphs.2020.01.027","article-title":"Pregnancy impacts entecavir pharmacokinetics but does not alter its renal excretion","volume":"109","author":"Lu","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tox.2024.153757_bib22","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1111\/bph.14756","article-title":"Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy","volume":"176","author":"Ma","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.tox.2024.153757_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/dmd.116.073304","article-title":"Multiple SLC and ABC transporters contribute to the placental transfer of entecavir","volume":"45","author":"Ma","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2024.153757_bib24","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1111\/bph.14756","article-title":"Roles of organic anion transporter 2 and equilibrative nucleoside transporter 1 in hepatic disposition and antiviral activity of entecavir during non-pregnancy and pregnancy","volume":"176","author":"Ma","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.tox.2024.153757_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fct.2015.02.009","article-title":"Theanine prevents doxorubicin-induced acute hepatotoxicity by reducing intrinsic apoptotic response","volume":"78","author":"Nagai","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tox.2024.153757_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010255","article-title":"Expression and functional contribution of different organic cation transporters to the cellular uptake of doxorubicin into human breast cancer and cardiac Tissue","volume":"23","author":"Otter","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2024.153757_bib27","article-title":"Expression and functional contribution of different organic cation transporters to the cellular uptake of doxorubicin into human breast cancer and cardiac tissue","volume":"23","author":"Otter","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2024.153757_bib28","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/bcp.13070","article-title":"Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma","volume":"82","author":"Perez-Blanco","year":"2016","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.tox.2024.153757_bib29","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/jcb.25890","article-title":"Oxidative stress promotes doxorubicin-induced Pgp and BCRP expression in colon cancer cells under hypoxic conditions","volume":"118","author":"Pinz\u00f3n-Daza","year":"2017","journal-title":"J. Cell Biochem"},{"key":"10.1016\/j.tox.2024.153757_bib30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1080\/00498254.2018.1498560","article-title":"Dioscorea bulbifera L. delays the excretion of doxorubicin and aggravates doxorubicin-induced cardiotoxicity and nephrotoxicity by inhibiting the expression of P-glycoprotein in mice liver and kidney","volume":"49","author":"Qu","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2024.153757_bib31","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.xphs.2016.02.023","article-title":"Localization of xenobiotic transporter OCTN1\/SLC22A4 in hepatic stellate cells and its protective role in liver fibrosis","volume":"105","author":"Tang","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tox.2024.153757_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-020-06941-x","article-title":"The role of AMPK activation for cardioprotection in doxorubicin-induced cardiotoxicity","volume":"34","author":"Timm","year":"2020","journal-title":"Cardiovasc Drugs Ther."},{"key":"10.1016\/j.tox.2024.153757_bib33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.102.034140","article-title":"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin","volume":"302","author":"Wang","year":"2002","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tox.2024.153757_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pnpbp.2014.03.005","article-title":"Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action","volume":"53","author":"Wang","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.tox.2024.153757_bib35","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/AAC.00986-16","article-title":"Multiple drug transporters are involved in renal secretion of entecavir","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tox.2024.153757_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110627","article-title":"Inhibition of multiple uptake transporters in cardiomyocytes\/mitochondria alleviates doxorubicin-induced cardiotoxicity","volume":"382","author":"Yi","year":"2023","journal-title":"Chem. -Biol. Inter."},{"key":"10.1016\/j.tox.2024.153757_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.phymed.2018.01.009","article-title":"Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products","volume":"40","author":"Yu","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.tox.2024.153757_bib38","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tox.2024.153757_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051184","article-title":"The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy","volume":"23","author":"Zilinyi","year":"2018","journal-title":"Molecules"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24000386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24000386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:57:21Z","timestamp":1759535841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X24000386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":39,"alternative-id":["S0300483X24000386"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2024.153757","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2024.153757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153757"}}